ArticleFrontiers in oncology2020

miR-125a Induces HER2 Expression and Sensitivity to Trastuzumab in Triple-Negative Breast Cancer Lines.

Lihi Ninio-Many et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.